39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Yao F, Ma L. piRNA-unbound PIWIL1 promotes metastasis. Nature Cell Biology. PMID 32203422 DOI: 10.1038/S41556-020-0502-3  0.339
2020 Zhang Y, Shi J, Xiao Z, Lei G, Liu X, Lee H, Koppula P, Cheng W, Mao C, Zhuang L, Ma L, Li W, Gan B. Abstract 2415: H2A monoubiquitination links glucose availability to epigenetic regulation of the endoplasmic reticulum stress induced cell death in cancer Cancer Research. 80: 2415-2415. DOI: 10.1158/1538-7445.Am2020-2415  0.305
2018 Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, Lee H, Zhou Z, Gan B, Nakagawa S, Ellis MJ, ... ... Ma L, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nature Genetics. PMID 30349115 DOI: 10.1038/S41588-018-0252-3  0.357
2018 Yao F, Zhou Z, Kim J, Hang Q, Xiao Z, Ton BN, Chang L, Liu N, Zeng L, Wang W, Wang Y, Zhang P, Hu X, Su X, Liang H, ... ... Ma L, et al. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity. Nature Communications. 9: 2269. PMID 29891922 DOI: 10.1038/S41467-018-04620-Y  0.312
2018 Zhang P, Xiao Z, Wang S, Zhang M, Wei Y, Hang Q, Kim J, Yao F, Rodriguez-Aguayo C, Ton BN, Lee M, Wang Y, Zhou Z, Zeng L, Hu X, ... ... Ma L, et al. ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer. Cell Reports. 23: 823-837. PMID 29669287 DOI: 10.1016/J.Celrep.2018.03.078  0.355
2018 Ge Z, Leighton JS, Wang Y, Peng X, Chen Z, Chen H, Sun Y, Yao F, Li J, Zhang H, Liu J, Shriver CD, Hu H, Piwnica-Worms H, ... Ma L, et al. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. Cell Reports. 23: 213-226.e3. PMID 29617661 DOI: 10.1016/J.Celrep.2018.03.047  0.355
2017 Kim J, Yao F, Xiao Z, Sun Y, Ma L. MicroRNAs and metastasis: small RNAs play big roles. Cancer Metastasis Reviews. PMID 29234933 DOI: 10.1007/S10555-017-9712-Y  0.337
2016 Xiao Z, Zhang P, Ma L. The role of deubiquitinases in breast cancer. Cancer Metastasis Reviews. PMID 27844253 DOI: 10.1007/S10555-016-9640-2  0.367
2016 Kim J, Siverly AN, Chen D, Wang M, Yuan Y, Wang Y, Lee H, Zhang J, Muller WJ, Liang H, Gan B, Yang X, Sun Y, You MJ, Ma L. Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways. Cancer Research. PMID 27569213 DOI: 10.1158/0008-5472.Can-16-1571  0.338
2016 Hyemin L, Dai F, Zhuang L, Xiao ZD, Kim J, Zhang Y, Ma L, You MJ, Wang Z, Gan B. BAF180 regulates cellular senescence and hematopoietic stem cell homeostasis through p21. Oncotarget. PMID 26992241 DOI: 10.18632/Oncotarget.8102  0.34
2015 Zhang P, Sun Y, Ma L. ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle (Georgetown, Tex.). 14: 481-7. PMID 25607528 DOI: 10.1080/15384101.2015.1006048  0.366
2015 Ma L. Abstract BS2-2: Targeting the LIFR-Hippo-YAP pathway as an anti-metastatic strategy Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Bs2-2  0.412
2014 Sun Y, Zhang J, Ma L. α-catenin. A tumor suppressor beyond adherens junctions. Cell Cycle (Georgetown, Tex.). 13: 2334-9. PMID 25483184 DOI: 10.4161/Cc.29765  0.34
2014 Zhang P, Wang L, Rodriguez-Aguayo C, Yuan Y, Debeb BG, Chen D, Sun Y, You MJ, Liu Y, Dean DC, Woodward WA, Liang H, Yang X, Lopez-Berestein G, Sood AK, ... ... Ma L, et al. miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nature Communications. 5: 5671. PMID 25476932 DOI: 10.1038/Ncomms6671  0.324
2014 Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y, Zhang J, Yuan J, Wang M, Chen D, Sun Y, Woodward WA, Liu Y, Dean DC, Liang H, Hu Y, ... ... Ma L, et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nature Cell Biology. 16: 864-75. PMID 25086746 DOI: 10.1038/Ncb3013  0.336
2014 Chen D, Sun Y, Yuan Y, Han Z, Zhang P, Zhang J, You MJ, Teruya-Feldstein J, Wang M, Gupta S, Hung MC, Liang H, Ma L. miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion. Plos Genetics. 10: e1004177. PMID 24586203 DOI: 10.1371/Journal.Pgen.1004177  0.341
2014 Piao HL, Yuan Y, Wang M, Sun Y, Liang H, Ma L. α-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-κB signalling. Nature Cell Biology. 16: 245-54. PMID 24509793 DOI: 10.1038/Ncb2909  0.351
2014 Lin A, Piao HL, Zhuang L, Sarbassov dos D, Ma L, Gan B. FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway. Cancer Research. 74: 1682-93. PMID 24448243 DOI: 10.1158/0008-5472.Can-13-1729  0.381
2014 Zhang J, Zhang P, Wang L, Piao HL, Ma L. Long non-coding RNA HOTAIR in carcinogenesis and metastasis. Acta Biochimica Et Biophysica Sinica. 46: 1-5. PMID 24165275 DOI: 10.1093/Abbs/Gmt117  0.311
2014 Wang L, Zhang P, Molkentine DP, Piao H, Chen C, Molkentine JM, Zhang J, Valdecanas DR, Skinner H, Buchholz TA, Chen J, Ma L, Mason KA, Ang K, Meyn RE. Abstract 4895: P16INK4A, a surrogate marker of HPV infection and prognosis for head and neck cancer, delays DNA damage repair and enhances radiation response Cancer Research. 74: 4895-4895. DOI: 10.1158/1538-7445.Am2014-4895  0.305
2013 Zhang J, Zhang P, Wei Y, Piao HL, Wang W, Maddika S, Wang M, Chen D, Sun Y, Hung MC, Chen J, Ma L. Deubiquitylation and stabilization of PTEN by USP13. Nature Cell Biology. 15: 1486-94. PMID 24270891 DOI: 10.1038/Ncb2874  0.366
2013 Ma L. Abstract B43: A novel breast cancer metastasis suppressor upstream of Hippo signaling Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B43  0.395
2012 Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein J, Gupta S, Liang H, Lin HK, Hung MC, Ma L. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker. Nature Medicine. 18: 1511-7. PMID 23001183 DOI: 10.1038/Nm.2940  0.391
2012 Zhang J, Ma L. MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Reviews. 31: 653-62. PMID 22684369 DOI: 10.1007/S10555-012-9368-6  0.342
2012 Piao HL, Ma L. Non-Coding RNAs as Regulators of Mammary Development and Breast Cancer Journal of Mammary Gland Biology and Neoplasia. 17: 33-42. PMID 22350981 DOI: 10.1007/S10911-012-9245-5  0.303
2010 Ma L. Role of miR-10b in breast cancer metastasis Breast Cancer Research. 12. PMID 21067538 DOI: 10.1186/Bcr2720  0.35
2010 Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW, Weinberg RA. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nature Biotechnology. 28: 341-7. PMID 20351690 DOI: 10.1038/Nbt.1618  0.312
2010 Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nature Cell Biology. 12: 247-56. PMID 20173740 DOI: 10.1038/Ncb2024  0.347
2009 Distefano G, Boca M, Rowe I, Wodarczyk C, Ma L, Piontek KB, Germino GG, Pandolfi PP, Boletta A. Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1. Molecular and Cellular Biology. 29: 2359-71. PMID 19255143 DOI: 10.1128/Mcb.01259-08  0.494
2008 Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC, Papa A, Nardella C, Cantley LC, Baselga J, Pandolfi PP. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer Journal of Clinical Investigation. 118: 3065-3074. PMID 18725988 DOI: 10.1172/Jci34739  0.509
2008 Ma L, Weinberg RA. Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends in Genetics : Tig. 24: 448-56. PMID 18674843 DOI: 10.1016/J.Tig.2008.06.004  0.371
2008 Ma L, Weinberg RA. MicroRNAs in malignant progression. Cell Cycle (Georgetown, Tex.). 7: 570-2. PMID 18256538 DOI: 10.4161/Cc.7.5.5547  0.318
2008 Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer (Nature (2007) 449, (682-688)) Nature. 455: 256. DOI: 10.1038/Nature07316  0.315
2007 Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 449: 682-8. PMID 17898713 DOI: 10.1038/Nature06174  0.352
2007 Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, Witte D, Cordon-Cardo C, Pandolfi PP. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Cancer Research. 67: 7106-12. PMID 17671177 DOI: 10.1158/0008-5472.Can-06-4798  0.496
2007 Hernando E, Charytonowicz E, Dudas ME, Menendez S, Matushansky I, Mills J, Socci ND, Behrendt N, Ma L, Maki RG, Pandolfi PP, Cordon-Cardo C. The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Nature Medicine. 13: 748-53. PMID 17496901 DOI: 10.1038/Nm1560  0.492
2005 Ma L, Teruya-Feldstein J, Behrendt N, Chen Z, Noda T, Hino O, Cordon-Cardo C, Pandolfi PP. Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes & Development. 19: 1779-86. PMID 16027168 DOI: 10.1101/Gad.1314405  0.473
2005 Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell. 121: 179-93. PMID 15851026 DOI: 10.1016/J.Cell.2005.02.031  0.472
2004 Ruggero D, Montanaro L, Ma L, Xu W, Londei P, Cordon-Cardo C, Pandolfi PP. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nature Medicine. 10: 484-6. PMID 15098029 DOI: 10.1038/Nm1042  0.574
Show low-probability matches.